Recently, an abnormality of vitamin D metabolism has been regarded as one of the pathogenesis for senile or postmenopausal osteoporosis. Okano et al.(1976) reported that serum 25-hydroxyvitamin D (25-OH-D) was decreased in senile osteoporosis, while some other group reported that it was normal or rather increased in that disease (Lund et al., 1975) . However, the role of1, 25-dihydroxyvitamim D [1, 25(OH)2D3, an active vitamin D metabolite, in the pathogenesis of senile osteoporosis has not been completely elucidated yet.
In the present study, serum1, 25(OH)2D level was determined in parallel with the determinations of serum parathyroid hormone (PTH), calcitonin (CT) and other parameters in senile or postmenopausal osteoporosis, in order to elucidate the pathogenesis for senile or postmenopausal osteoporosis from an endocrine standpoint of view. for labeling (Inolex Co., Ltd.) was iodinated with125I-Na by the chloramine-T method followed by purifica- 
Results
A. Corrected serum calcium, serum inorganic phosphorus and serum Al-P'ase levels in senile osteoporosis
As shown in Fig.1 , corrected serum calcium level in the osteoporotic group with porosis score II or III, was within normal limits but significantly increased compared to that in the age-matched normal group (P<0.05, P<0.01, respectively). As shown in Fig.2and  Fig.3 , there was no significant difference between normal group and osteoporotic groups either in serum inorganic phosphorus or in serum Al-P'ase, although serum Al-P'ase tended to decrease in the osteoporotic group with porosis score III.
B. Serum PTH and serum CT in senile osteoporosis
As shown in Fig.4 , the detection rate of serum PTH was increased in all stages of senile osteoporosis and some patients revealed high PTH levels, while it was detected only in3of10normal subjects. As shown in Fig.5 , serum CT level did was no significant correlation between any of serum1, 25 (OH) 2D, PTH or CT and any of corrected serum calcium, serum inorganic phosphorus or serum Al-Pase either in normal group or in osteoporotic groups.
Discussion
Osteoporosis in the aged human subjects is called senile osteoporosis and especially in women postmenopausal osteoporosis. The incidence of osteoporosis starts to increase around the age of50, and its incidence is much higher in women than in men. Recently, we reported that serum 25-OH-D decreased with advancing age and in senile osteoporosis (Okano et al., 1976) , suggesting an abnormality in vitamin D metabolism as one of the pathogenesis for senile osteoporosis, while it was reported that serum 25-OH-D was normal or rather increased in osteoporosis (Lund et al., 1975) . Such an inconsistency in serum 25-OH-D level in osteoporotic patients prompted us to determine serum1, 25 (OH) 2D, an active vitamin D metabolite, in parallel with the determinations of serum PTH and CT levels in senile osteoporosis, in order to elucidate the pathogenesis for senile osteoporosis from an endocrine standpoint of view.
Our present result that serum1, 25-(OH) 2D level is decreased in advanced senile osteoporosis with porosis score III often accompanied by vertebral compression fractures, coincides with a report by DeLuka (1978) . However, a decrease of serum1, 25 (OH) 2D level seems not to be the only factor in the pathogenesis of senile osteoporosis, because serum1, 25 (OH) 2D was not necessarily decreased in a slight to moderate degree of senile osteoporosis in the present study. Davies et al.(1977) reported that no abnormality in vitamin D metabolism was detected in osteoporotic patients with vertebral compression fractures in his study observing the response of bone to a small dose of1, 25 (OH) 2D3. Supernormal or high level of serum PTH in all stages of senile osteoporosis in the present study coincides with a report by Teitelbaum et al.(1976) .
The present data that serum calcium is significantly increased and serum PTH is relatively higher than normal in advanced osteoporosis, implys a possibility that a decrease in serum1, 25 (OH) 2D level,. directly (Okano et al., 1979) or indirectly through a decrease of intestinal calcium absorption, would induce an increase of PTH secretion leading to an increase of bone resorption. On the other hand, normal serum1, 25 (OH) 2D level and rather increased serum PTH level in a slight to moderate degree of senile osteoporosis in the present study would imply a probability that some abnormality in the receptors of the target organs to1, 25 (OH) 2D3 and /or some other factors than1, 25 (OH) 2D3, for instance, a decrease of calcium intake, agedependent decrease of intestinal calcium absorption and a lack of oestrgen, might be playing a role for an increase of serum PTH level leading to an increase of bone resorption.
As to the role of estrogen in the pathogenesis of senile or postmenopausal osteoporosis, it is known that estrogen mainly inhibits bone resorption. It is also reported. that the sensitivity of bone to PTH would be increased in postmenopausal osteoporosis. as a result of a decrease of serum estrogen level. Recently, Tanaka et al.(1976) reported that estradiol in combination with testosterone promoted the conversion of 25-OH-D3 to1, 25 (OH) 2D3 in chick kidney. Riggs (1978) reported that an administration of estradiol to osteoporotic patients. increased serum1, 25 (OH) 2D level and improved intestinal calcium absorption. On the other hand, it is also reported that estrogen preparation administered for long period eventually decreased bone formation. (Riggs et al., 1972 progressive bone demineralization was observed, although estrogen seems clearly to delay bone loss lasting at least10to15 years (Davis et al., 1966) . In fact, we could not observe a significant difference in serum estradiol level between osteoporotic patients and age-matched normal controls in spite of a significant decrease of serum 25-OH-D level in these osteoporotic patients (Okano et al., 1976) .
Contrary to the present results and the report by Teitelbaum et al.(1976) as to the complication of secondary hyperparathyroidism in osteoporosis, it was reported that serum PTH was low in senile osteoporosis (Rigge et al., 1973) and that only about 10% of osteoporotic patiens represented secondary hyperparathyroidism (Riggs, 1978) . Furthermore, Riggs (1978) proposed to classify osteoporosis into several categories from a standpoint of vitamin D metabolism: 1) disturbance of 25-hydroxylase in liver (decreased serum 25-OH-D), 2) disturbance of1a-hydroxylase in kidney (increased serum 25-OH-D), 3) insufficient substrates due to nutritional deficiency (decreased serum 25-OH-D), and4) unrelated to vitamin D metabolism. However, further detailed investigation covering a large numer of cases of osteoporosis seems to be necessary for the validation of this proposal. For the time being, it appears to be appropriate to regard osteoporosis as a syndrome induced by various causes. And it will be mandatory to classify osteoporosis by the age of its onset, the sex and nutritional conditions of the osteoporotic patients and so forth for the further elucidation of its pathogenesis.
Furthermore, recent reports that24, 25-dihydroxyvitamin D3 [24, 25 (OH) 2D3] is indispensable for normal hatching of chick embryo (Henry and Norman, 1978) and directly inhibited PTH secretion (Okano et al., 1979) and the recent isolation of a low molecular-weight Gla containing protein from bone (Hauschka et al., 1975) would necessitate the investigations on the role of 24, 25 (OH) 2D3 and other unknown vitamin D metabolites as well as vitamin K-dependent bone protein in osteoporosis for further elucidation of its pathogenesis.
